While it functions as a tumor suppressor in prostate, colon, breast and lung epithelial cells, where it protects from neuroendocrine transformation, REST/NRSF shows tumor-promoting functions in medulloblastoma and glioma, ovarian and pancreatic cancers [151,152,153,154,155,156]. This evidence concerns the gene REST and glioma.